Dli Pharmaceuticals India Private Limited
About Dli Pharmaceuticals India Private Limited
Data last updated:
Dli Pharmaceuticals India Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2021PTC150619. Its GSTIN is 09AAICD6818J1Z8 (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Anita Gupta and Scott Antone Gubler.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 203 Parsvnath Prestige Sector – 93A Maharishi Nagar Bajidpur, Noida, Uttar Pradesh, India – 201304.
As per the financials filed for FY 2025, the company reported a revenue of ₹22,513, a decline of 80% compared to the previous year. For the same year it recorded a net loss of ₹15,329 (net margin -68.1%) and EBITDA of -₹8,897 (EBITDA margin -39.5%).
Company details
Contact details
Dli Pharmaceuticals India Private Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressE – 203 Parsvnath Prestige Sector – 93A Maharishi Nagar Bajidpur, Noida, Uttar Pradesh, India – 201304
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Dli Pharmaceuticals India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dli Pharmaceuticals India is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Dli Pharmaceuticals India Private Limited, buy the company report.
Financials of Dli Pharmaceuticals India Private Limited
FY 2025 filings availableDli Pharmaceuticals India Private Limited reported revenue of ₹22,513 (down 80% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 80% in the latest year. EBITDA fell 520% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹8,897 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹15,329 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -39.5% | |||
| Net Profit Margin | -68.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Dli Pharmaceuticals India Private Limited, buy the company report.
Board of directors of Dli Pharmaceuticals India Private Limited
Dli Pharmaceuticals India has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anita Gupta | Director | 12 Aug 2021 | 5 Years 2 Months | Current |
| Scott Antone Gubler | Director | 12 Aug 2021 | 5 Years 2 Months | Current |
| Mark Henry Gubler | Director | 12 Aug 2021 | 5 Years 2 Months | Current |
Auditor
Dli Pharmaceuticals India Private Limited is audited by M A G AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M A G AND CO | FY 2023 | 099517 |
Shareholding
The shareholding of Dli Pharmaceuticals India Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Dli Pharmaceuticals India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dli Pharmaceuticals India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dli Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dli Pharmaceuticals India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICD6818J1Z8 | Uttar Pradesh | Active | 23 Nov 2021 |
To see the full GST registrations and return filing status of Dli Pharmaceuticals India Private Limited, buy the company report.
Recent activity
Dli Pharmaceuticals India Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Anita Gupta was appointed as Director on 12 Aug 2021.
Frequently asked questions
Dli Pharmaceuticals India is an active private limited company based in Noida, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 August 2021 (5+ years old) and is registered under CIN U51909UP2021PTC150619.
Dli Pharmaceuticals India has 3 current directors:
- Anita Gupta - Director
- Scott Antone Gubler - Director
- Mark Henry Gubler - Director
The latest financial statements of Dli Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Dli Pharmaceuticals India is 09AAICD6818J1Z8, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Dli Pharmaceuticals India is U51909UP2021PTC150619. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dli Pharmaceuticals India was incorporated on 12 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kanpur.
Anita Gupta was appointed as Director on 12 Aug 2021. Mark Henry Gubler was appointed as Director on 12 Aug 2021. Scott Antone Gubler was appointed as Director on 12 Aug 2021.
The registered office of Dli Pharmaceuticals India is at E – 203 Parsvnath Prestige Sector – 93A Maharishi Nagar Bajidpur, Noida, Uttar Pradesh, India – 201304.
Dli Pharmaceuticals India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Dli Pharmaceuticals India can be reached at its registered office: E – 203 Parsvnath Prestige Sector – 93A Maharishi Nagar Bajidpur, Noida, Uttar Pradesh, India – 201304.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
